Redmond Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,745
Closed -$565K 169
2017
Q4
$565K Sell
10,745
-25,243
-70% -$1.35M 0.24% 112
2017
Q3
$1.7M Sell
35,988
-25,004
-41% -$1.01M 0.77% 47
2017
Q2
$2.16M Sell
60,992
-25,671
-30% -$792K 1.01% 34
2017
Q1
$2.05M Buy
86,663
+778
+0.9% +$15.4K 1.05% 28
2016
Q4
$1.15M Sell
85,885
-12
-0% -$194 0.53% 65
2016
Q3
$1.59M Buy
85,897
+375
+0.4% +$6.61K 0.78% 53
2016
Q2
$1.05M Hold
85,522
0.52% 72
2016
Q1
$576K Buy
85,522
+48,623
+132% +$311K 0.29% 100
2015
Q4
$341K Buy
36,899
+250
+0.7% +$2.33K 0.18% 114
2015
Q3
$659K Buy
36,649
+5,267
+17% +$121K 0.35% 99
2015
Q2
$933K Buy
31,382
+360
+1% +$9.04K 0.46% 71
2015
Q1
$683K Buy
+31,022
New +$787K 0.34% 86

Other funds holding EXAS

Redmond Asset Management's EXAS Position: Q1 2018 in Review

Redmond Asset Management sold out of Exact Sciences (EXAS) in Q1 2018, closing a stake of 10,745 shares — an estimated $565K sold.

Redmond Asset Management first reported a position in EXAS in Q1 2015 and held it in 12 quarters. The position peaked at $2.16M in Q2 2017. 319 funds tracked by Wall St. Rank hold EXAS as of Q1 2018.

  • Redmond Asset Management reported no remaining Exact Sciences position as of Q1 2018 after selling out during the quarter.
  • Redmond Asset Management sold 10,745 Exact Sciences shares in Q1 2018, an estimated $565K.
  • Redmond Asset Management first reported a position in Exact Sciences in Q1 2015 and held it in 12 quarters.
  • Redmond Asset Management's Exact Sciences position peaked at $2.16M in Q2 2017.
  • 319 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2018.

Based on Redmond Asset Management's 13F filing for Q1 2018, filed 7 May 2018.